-
[Latest] Global Propylene Glycol Market Size/Share Worth USD 7.03 Billion by 2034 at a 4.23% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
17 Jul 2025 16:30 GMT
… production methods, companies investing in the manufacture … chunk of market share. Emerging markets also present … Growth Drivers, Restraints, Investment Opportunities, and Leading Trends … End User (Pharmaceutical, Biotechnology, Medical Device Manufacturers, …
-
FDA Clinical Hold on RP-A501 Trial Triggers Rocket Pharmaceuticals (RCKT) Stock Plunge and Class Action– Hagens Berman
17 Jul 2025 19:07 GMT
… investors in the company’s shares saw their investment crash … Rocket Pharmaceuticals, a biotechnology company developing gene therapies … artificially inflated stock price, and investors suffered heavy … investigation. If you invested in Rocket Pharmaceuticals …
-
Ghana, Serbia target stronger trade ties and investment partnerships
17 Jul 2025 18:40 GMT
… therefore, urged Serbian investors to take full advantage … trade and investment partnerships in emerging markets, particularly in … future cooperation.”
The Foreign Minister added that the … economies.
Serbia’s biotechnology institutes and agricultural research …
-
Here’s what’s exciting food tech investors in 2025
17 Jul 2025 15:54 GMT
… grant funding, pursue debt financing, or for those with … to seek venture capital investment. Whether it’s for …
Sustainable ingredients driven by biotechnology
The AI revolution is … food?
Join a global community of innovators, investors, and industry leaders …
-
Ocugen to Host Conference Call on Friday, August 1 at 8:30 A.M. ET to Discuss Business Updates and Second Quarter 2025 Financial Results
17 Jul 2025 10:30 GMT
… : OCGN), a pioneering biotechnology leader in gene therapies … s second quarter 2025 financial results and provide … 646) 307-1963 for international callers
Conference ID: 9627149 … investor site. About Ocugen, Inc.
Ocugen, Inc. is a pioneering biotechnology …
-
Zymeworks to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025
17 Jul 2025 10:00 GMT
… its second quarter 2025 financial results after market close … the following upcoming investor conferences:
BTIG Virtual Biotechnology Conference: Zymeworks’ … leveraged through strategic partnerships with global biopharmaceutical companies. For information …
-
Healthcare Third‑party Logistics Market 2025–2034 : Size, Share & Competitive Landscape – Forecasting at (7.8% CAGR)
17 Jul 2025 09:33 GMT
… demands substantial upfront investment and ongoing operational … smaller players. This financial barrier limits the … medical device manufacturing companies, biotechnology companies, and others. … Kuehne and Nagel, Expeditors International, CH Robinson Worldwide, …
-
Ascentage Pharma Announces Closing of Placement Shares in Top-Up Placement
17 Jul 2025 08:30 GMT
… Limited and Citigroup Global Markets Limited, each in … Pharma Group International Ascentage Pharma Group International (NASDAQ: … global partnerships and other relationships with numerous leading biotechnology … by law. Contacts
Investor Relations:
Hogan Wan, …
-
One Biosciences Announces €15 Million Series A Financing to Advance Clinical Single Cell Profiling
17 Jul 2025 07:50 GMT
… partnerships with pharmaceutical and biotechnology companies
Financing led by Redmile Group … from this group of leading global investors reinforces our conviction and … Institute, commented: "This investment coupled with our established capacity …
-
[Latest] Global Blue Ammonia Market Size/Share Worth USD 458.74 Billion by 2034 at a 55.26% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
16 Jul 2025 08:30 GMT
… Global Industry Overview, Statistical Data, Competitive Analysis, Share … of the international cooperation required to … Growth Drivers, Restraints, Investment Opportunities, and Leading … End User (Pharmaceutical, Biotechnology, Medical Device Manufacturers, …